These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 10951341

  • 1. Prognostic impact of P53 status in Ewing sarcoma.
    de Alava E, Antonescu CR, Panizo A, Leung D, Meyers PA, Huvos AG, Pardo-Mindán FJ, Healey JH, Ladanyi M.
    Cancer; 2000 Aug 15; 89(4):783-92. PubMed ID: 10951341
    [Abstract] [Full Text] [Related]

  • 2. Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse.
    Huang HY, Illei PB, Zhao Z, Mazumdar M, Huvos AG, Healey JH, Wexler LH, Gorlick R, Meyers P, Ladanyi M.
    J Clin Oncol; 2005 Jan 20; 23(3):548-58. PubMed ID: 15659501
    [Abstract] [Full Text] [Related]

  • 3. C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.
    Scotlandi K, Manara MC, Strammiello R, Landuzzi L, Benini S, Perdichizzi S, Serra M, Astolfi A, Nicoletti G, Lollini PL, Bertoni F, Nanni P, Picci P.
    J Clin Oncol; 2003 May 15; 21(10):1952-60. PubMed ID: 12743148
    [Abstract] [Full Text] [Related]

  • 4. STAT3 is activated in a subset of the Ewing sarcoma family of tumours.
    Lai R, Navid F, Rodriguez-Galindo C, Liu T, Fuller CE, Ganti R, Dien J, Dalton J, Billups C, Khoury JD.
    J Pathol; 2006 Apr 15; 208(5):624-32. PubMed ID: 16463269
    [Abstract] [Full Text] [Related]

  • 5. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro.
    Chansky HA, Barahmand-Pour F, Mei Q, Kahn-Farooqi W, Zielinska-Kwiatkowska A, Blackburn M, Chansky K, Conrad EU, Bruckner JD, Greenlee TK, Yang L.
    J Orthop Res; 2004 Jul 15; 22(4):910-7. PubMed ID: 15183454
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
    Castillero-Trejo Y, Eliazer S, Xiang L, Richardson JA, Ilaria RL.
    Cancer Res; 2005 Oct 01; 65(19):8698-705. PubMed ID: 16204038
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis.
    Abudu A, Mangham DC, Reynolds GM, Pynsent PB, Tillman RM, Carter SR, Grimer RJ.
    Br J Cancer; 1999 Mar 01; 79(7-8):1185-9. PubMed ID: 10098757
    [Abstract] [Full Text] [Related]

  • 9. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
    Hahm KB, Cho K, Lee C, Im YH, Chang J, Choi SG, Sorensen PH, Thiele CJ, Kim SJ.
    Nat Genet; 1999 Oct 01; 23(2):222-7. PubMed ID: 10508522
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Molecular detection of EWS-Ets fusion transcripts and their clinicopathologic significance in Ewing's sarcoma/peripheral primitive neuroectodermal tumor.
    Wang H, Zheng J, Wang YP, Yang Y, You JF.
    Chin Med J (Engl); 2005 Aug 20; 118(16):1323-9. PubMed ID: 16157025
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity.
    Myatt SS, Burchill SA.
    Oncogene; 2008 Feb 07; 27(7):985-96. PubMed ID: 17700534
    [Abstract] [Full Text] [Related]

  • 14. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.
    Girnita L, Girnita A, Wang M, Meis-Kindblom JM, Kindblom LG, Larsson O.
    Oncogene; 2000 Aug 31; 19(37):4298-301. PubMed ID: 10980604
    [Abstract] [Full Text] [Related]

  • 15. Adenovirus E1A does not induce the Ewing tumor-associated gene fusion EWS-FLI1.
    Kovar H, Fallaux FJ, Pribill I, Jugovic D, Bartl S, Ambros PF, Aryee DN, Wiegant JC, Hoeben RC.
    Cancer Res; 2000 Mar 15; 60(6):1557-60. PubMed ID: 10749123
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of the transcriptional function of p53 by EWS-Fli1 chimeric protein in Ewing Family Tumors.
    Li Y, Tanaka K, Fan X, Nakatani F, Li X, Nakamura T, Takasaki M, Yamamoto S, Iwamoto Y.
    Cancer Lett; 2010 Aug 01; 294(1):57-65. PubMed ID: 20153576
    [Abstract] [Full Text] [Related]

  • 17. Primary cutaneous Ewing sarcoma/primitive neuroectodermal tumour: a clinicopathological analysis of seven cases highlighting diagnostic pitfalls and the role of FISH testing in diagnosis.
    Shingde MV, Buckland M, Busam KJ, McCarthy SW, Wilmott J, Thompson JF, Scolyer RA.
    J Clin Pathol; 2009 Oct 01; 62(10):915-9. PubMed ID: 19783720
    [Abstract] [Full Text] [Related]

  • 18. Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents.
    Mora J, de Torres C, Parareda A, Torner F, Galván P, Rodríguez E, Cardesa T, Salvador H, Suñol M, Huguet R, Cruz O.
    Pediatr Blood Cancer; 2011 Jul 15; 57(1):69-75. PubMed ID: 21384537
    [Abstract] [Full Text] [Related]

  • 19. Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types.
    Thorner P, Squire J, Chilton-MacNeil S, Marrano P, Bayani J, Malkin D, Greenberg M, Lorenzana A, Zielenska M.
    Am J Pathol; 1996 Apr 15; 148(4):1125-38. PubMed ID: 8644855
    [Abstract] [Full Text] [Related]

  • 20. Role of fusion subtype in Ewing sarcoma.
    Barr FG, Meyer WH.
    J Clin Oncol; 2010 Apr 20; 28(12):1973-4. PubMed ID: 20308653
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.